Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business.
Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an immunotherapy and targeted oncology company
What is covered in the Full Insight:
- Introduction
- Details of the Acquisition
- Strategic Benefits for Sun Pharma
- Financial Projections and Growth Outlook
- Conclusion and Analyst Opinion
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 18-minute read)
Discussions
(Paid Plans Only)
x